Professor, Internal Medicine, Oakland University Wm Beaumont SOM
Cardiology
Dr. Cindy L. Grines, MD
|
|
Give Review
Cindy L. Grines is an expert in the field of Cardiology. He received 4 awards: "Whos Who in Medicine and Healthcare", "Top MD", "Super Doctor" and "Fellow (FACC)". Doctor Cindy L. Grines, MD is a published doctor. He has 90 publications published. The most current publication "Impact of glycoprotein IIb/IIIa inhibitors use on outcomes after lower extremity endovascular interventions from nationwide inpatient sample (2006-2011)." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Treatment of Massive or Submassive Acute Pulmonary Embolism With Catheter-Directed Thrombolysis.
- Impact of glycoprotein IIb/IIIa inhibitors use on outcomes after lower extremity endovascular interventions from nationwide inpatient sample (2006-2011).
- Volume-outcome relationship for peripheral endovascular interventions: a review of existing literature.
- Coronary Atherectomy in the United States (from a Nationwide Inpatient Sample).
- In-Hospital Outcomes of Atherectomy During Endovascular Lower Extremity Revascularization.
- Intravascular Ultrasound in Lower Extremity Peripheral Vascular Interventions: Variation in Utilization and Impact on In-Hospital Outcomes From the Nationwide Inpatien...
- Transcatheter Aortic Valve Replacement: 2015 in Review.
- Percutaneous Coronary Intervention: 2015 in Review.
- Transcatheter pulmonary Valve implantation: A cross-sectional US experience.
- Impact of Hospital Volume on Outcomes of Endovascular Stenting for Adult Aortic Coarctation.
- Effect of Hospital Volume on Outcomes of Transcatheter Mitral Valve Repair: An Early US Experience.
- Comparison of the Usefulness of Enoxaparin Versus Warfarin for Prevention of Left Ventricular Mural Thrombus After Anterior Wall Acute Myocardial Infarction.
- Commentary on Highlighted late breaking trials in interventional cardiology at ESC, VIVA, TCT, and AHA 2013.
- Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States: Influence of Hospital...
- Impact on In-Hospital Outcomes With Drug-Eluting Stents Versus Bare-Metal Stents (from 665,804 Procedures).
- Comparison of Outcomes of Balloon Aortic Valvuloplasty Plus Percutaneous Coronary Intervention Versus Percutaneous Aortic Balloon Valvuloplasty Alone During the Same H...
- Impact of annual operator and institutional volume on percutaneous Coronary intervention outcomes: a 5-year United States experience (2005-2009).
- Impact of Symptoms, Gender, Co-Morbidities, and Operator Volume on Outcome of Carotid Artery Stenting (from the Nationwide Inpatient Sample [2006 to 2010]).
- Another Reason For Women to Avoid Estrogen?
- Results of Ventricular Septal Myectomy and Hypertrophic Cardiomyopathy (from Nationwide Inpatient Sample [1998-2010]).
- SCAI/ACC/AHA Expert Consensus Document: 2014 Update on Percutaneous Coronary Intervention Without On-Site Surgical Backup.
- Commentary on late breaking trials in interventional cardiology at ESC, VIVA, TCT, AHA (Fall 2012), and ACC 2013.
- Impact of Multiple Complex Plaques on Short- and Long-Term Clinical Outcomes in Patients Presenting With ST-Segment Elevation Myocardial Infarction (from the Harmonizi...
- Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet Glycoprotein IIb/IIIa Inhibitors: Insights From Blue Cross Blue Shield of...
- Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: A consensus statement of the society of c...
- Current percutaneous treatment strategies for saphenous vein graft Disease.
- Implications of Myocardial Reperfusion on Survival in Women Versus Men With Acute Myocardial Infarction Undergoing Primary Coronary Intervention.
- Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous Coronary intervention: Implications for patients requiri...
- Primary percutaneous Coronary intervention: the deception of delay.
- Effect of percutaneous Coronary intervention on quality of life: A consensus statement from the society for cardiovascular angiography and interventions.
- Comparison of abciximab versus eptifibatide during percutaneous Coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).
- The year in interventional cardiology.
- Acute coronary syndromes: from the emergency department to the catheterization laboratory-integrating evidence from recent ACS/NSTEMI trials into clinical practice: an...
- A nail in the coffin of troponin measurements after percutaneous Coronary intervention.
- Panel summary and recommendations on the role of thrombectomy with primary PCI for STEMI.
- The current role of AngioJet rheolytic thrombectomy in Acute myocardial infarction.
- When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADIL...
- Impact of delay to angioplasty in patients with Acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Int...
- Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary perc...
- Impact of thienopyridine administration prior to primary stenting in Acute myocardial infarction.
- Combining antiplatelet and anticoagulant therapies.
- Prognostic impact of blood transfusion after primary angioplasty for Acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investiga...
- Sex differences in response to treatments for chronic Coronary artery disease.
- A Bayesian meta-analysis comparing AngioJet thrombectomy to percutaneous coronary intervention alone in Acute myocardial infarction.
- Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in Acute myocardial infarction: results from the CADILLAC trial.
- The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale.
- Management of multivessel Coronary disease: let us not shortchange drug-eluting stents.
- Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused Myocardial infarction.
- A statement on ethics from the Heart Group.
- Should we routinely use drug-eluting stents for Acute myocardial infarction? Let's wait and see.
- A percutaneous Coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous c...
- Computed tomographic angiographic morphology of invasively proven complex Coronary plaques.
- Off-label use of drug-eluting stents putting it in perspective.
- Predictors of infarct size after primary coronary angioplasty in Acute myocardial infarction from pooled analysis from four contemporary trials.
- Effects of Ad5FGF-4 in patients with Angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials.
- Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for Acute myocardial infarction.
- Relation between leucocyte count, myonecrosis, Myocardial perfusion, and outcomes following primary angioplasty.
- Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in Acute myocardial infarction (from the CADILLAC trial).
- Impact of body mass index on outcomes after percutaneous coronary intervention in patients with Acute myocardial infarction.
- ACCF/AHA/CDC conference report on emerging infectious Diseases and biological terrorism threats: the clinical and public health implications for the prevention and con...
- Predictors of complete Heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation.
- Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for Acute myocardial infarction in patients not receiving gl...
- Effect of door-to-balloon time on patient mortality.
- Reproducible microvascular dysfunction with dobutamine infusion in Takotsubo Cardiomyopathy presenting with ST segment elevation.
- Safety of AngioJet thrombectomy in Acute ST-segment elevation myocardial infarction: a large, single-center experience.
- Impact of treatment delays on outcomes of primary percutaneous coronary intervention for Acute myocardial infarction: analysis from the CADILLAC trial.
- Transcatheter cardiovascular therapeutics annual meeting.
- Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for Acute myocardial infarction.
- Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous Coronary intervention: results from a 2-part, phase II, m...
- The role of statins in reversing atherosclerosis: what the latest regression studies show.
- Impact of body mass index on outcomes after primary angioplasty in Acute myocardial infarction.
- Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in Acute myocardial infarction (the CADILLAC registry).
- Should patients with Acute myocardial infraction be transferred to a tertiary center for primary angioplasty or receive it at qualified hospitals in the community? The...
- IntraCoronary fibrin-specific thrombolytic infusion facilitates percutaneous recanalization of chronic total occlusion.
- Letter regarding article by Nallamothu et al, "Times to treatment in transfer patients undergoing primary percutaneous Coronary intervention in the United states&...
- Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for Acute myocardial infarction.
- My vision for the journal of interventional cardiology.
- Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in Acute myocardial infarction.
- Impact of smoking status on outcomes of primary coronary intervention for Acute myocardial infarction--the smoker's paradox revisited.
- Left ventricular remodeling and systolic deterioration in Acute myocardial infarction: findings from the Stent-PAMI Study.
- Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for Acute myocardial infarction.
- Success, safety, and mechanisms of failure of percutaneous Coronary intervention for occlusive non-drug-eluting in-stent restenosis versus native artery total occlusion.
- Acute PCI for ST-segment elevation myocardial infarction: is later better than never?
- Alcohol septal ablation for hypertrophic obstructive Cardiomyopathy.
- Prediction of mortality after primary percutaneous coronary intervention for Acute myocardial infarction: the CADILLAC risk score.
- Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for Acute myocardial infarction: results of the Controlled ...
- Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with Acute myocardial infarction.
- Frequency of returning to work one and six months following percutaneous coronary intervention for Acute myocardial infarction.
- Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for Acute myocardial infarction.
Schools
Ohio State University College Of Medicine and Public Health
Ohio St University
University Of Michigan
Ohio State University
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Angioplasty With Stent Placement
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Preferred PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- Molina
- MultiPlan PPO
- Priority PPO
- Simplifi
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Whos Who in Medicine and Healthcare
- Top MD
- Super Doctor
- Fellow (FACC)
Education
-
University of Michigan Hospitals and Health Centers -
Ohio State University Hospital
Drug Facts
| NPI NUMBER | 1679532311 | |
| NPPES Provider LastName | GRINES | |
| NPPES Provider FirstName | CINDY | |
| NPPES Provider ZIPCode | 480341330 | |
| NPPES Provider State | MI | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1548.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679532311 |
| Last Name Of The Provider | GRINES |
| First Name Of The Provider | CINDY |
| View All |
Similar Doctors
|
|
Dr. Christian E. Machado, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hassan M. Ismail, MD |
|
|
Dr. Hanna K. Al-Makhamreh, MD |
|
|
Dr. Tareq Y. Goussous, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jamal X. Zarghami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anjani C. Rao, MD |
|
|
Dr. Patrick B. Alexander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammad H. Qureshi, MD
This Doctor is OpenDoctor Recommended.
|